A galactagogue, or galactogogue (from Greek: γάλα [γαλακτ-], milk, + ἀγωγός, leading), also known as a lactation inducer or milk booster, is a substance that promotes lactation in humans and other animals.[1][2] It may be synthetic, plant-derived, or endogenous. They may be used to induce lactation and to treat low milk supply.
Pharmaceutical
Synthetic galactagogues such as domperidone and metoclopramide interact with the dopamine system in such a way to increase the production of prolactin; specifically, by blocking the D2 receptor.[3]
There is some evidence to suggest that mothers who are unable to meet their infants' breastfeeding needs may benefit from galactogogues.[4][5]
A more recent study questions the effectiveness of commercial lactation cookies finding no significant difference.[6]
Galactagogues may be considered when non-pharmacologic interventions are found to be insufficient.[7][8] For example, domperidone may be an option for mothers of preterm babies who at over 14 days from delivery and after full lactation support still have difficulty expressing breast milk in sufficient quantity for their child's needs.[9] Lactation induction may also be possible in certain circumstances for women planning to adopt an infant.[10]
Domperidone (like metoclopramide, a D2 receptor antagonist) is not approved for enhanced lactation in the USA.[11][12] By contrast, Australian guidelines consider domperidone to be the preferred galactagogue when non-pharmacological approaches have proved insufficient.[7] Unlike metoclopramide, domperidone does not cross the blood–brain barrier and does not tend to have adverse effects such as drowsiness or depression.[7]
Herbals and foods used as galactagogues have little or no scientific evidence of efficacy, and the identity and purity of herbals are concerns because of inadequate testing requirements.[17]
The herbals most commonly cited as galactagogues are:[17]
Milk thistle (Silybum marianum);[17] in 2010 the European Food Safety Authority considered and rejected a claim for silybum as a galactagogue because the evidence was deemed insufficient.[citation needed]
^Forinash AB, Yancey AM, Barnes KN, Myles TD (2012). "The use of galactogogues in the breastfeeding mother". Ann Pharmacother. 46 (10): 1392–404. doi:10.1345/aph.1R167. PMID23012383. S2CID207264697.
^Forinash AB, Yancey AM, Barnes KN, Myles TD (October 2012). "The use of galactogogues in the breastfeeding mother". Ann Pharmacother. 46 (10): 1392–404. doi:10.1345/aph.1R167. PMID23012383. S2CID207264697.
^The Academy Of Breastfeeding Medici (2011). "ABM Clinical Protocol #9: Use of Galactogogues in Initiating or Augmenting the Rate of Maternal Milk Secretion (First Revision January 2011)". Breastfeeding Medicine. 6 (1): 41–49. doi:10.1089/bfm.2011.9998. PMID21332371.
^Conneely OM, Mulac-Jericevic B, Arnett-Mansfield R (2007). "Progesterone signaling in mammary gland development". Ernst Schering Found Symp Proc. Ernst Schering Foundation Symposium Proceedings. 2007 (1): 45–54. doi:10.1007/2789_2008_075. ISBN978-3-540-73492-5. PMID18543434.
^Damanik R, Wahlqvist ML, Wattanapenpaiboon N (2006). "Lactagogue effects of Torbangun, a Bataknese traditional cuisine". Asia Pac J Clin Nutr. 15 (2): 267–74. PMID16672214.